FDA Ruling on Statin Therapy

Published Online: Wednesday, December 19, 2012
Follow Pharmacy_Times:
In this video, David Dichek, MD, of the University of Washington Medical Center, discusses an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins. He also discusses how to address concerns that patients may have about taking statins in light of the waning.

Related Articles
Patients with limited life expectancy may see improvement in their quality of life if they stop taking statins.
Including often-ignored random blood glucose values in screening guidelines could help clinicians detect diabetes risk.
The FDA announced today that it will permit the marketing of a mobile medical app that will help patients with diabetes share data from a continuous glucose monitor with other individuals.
Older diabetics with multiple comorbid conditions often receive aggressive treatment regardless of their health status or blood sugar levels.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$